Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 299
Selected: 0
NCT IDTitle
NCT01800071A Phase Ib Trial of MVA-EBNA1/LMP2 Vaccine in Nasopharyngeal Carcinoma
NCT01390571Olaparib and Temozolomide in Treating Patients With Relapsed Glioblastoma
NCT01737255Magnetic Resonance Imaging Screening in Li Fraumeni Syndrome
NCT02530411Fulvestrant +/- Vandetanib in Advanced Aromatase Inhibitor Resistant Breast Cancer
NCT02544308Trial of Immunomodulatory Therapy in High Risk Solitary Bone Plasmacytoma
NCT03728881Single Dose of Cervarix Vaccine in Girls or Three Doses of Gardasil Vaccine in Women for the Prevention of Human Papillomavirus Infection, the PRIMAVERA-ESCUDDO Trial
NCT04648033Atovaquone With Radical ChemorADIotherapy in Locally Advanced NSCLC
NCT00720447Donor Stem Cell Transplant in Treating Patients With Mantle Cell Lymphoma
NCT01398085IoN- Is Ablative Radio-iodine Necessary for Low Risk Differentiated Thyroid Cancer Patients
NCT02752204An Evaluation AZD2014 Alone and in Combination With Rituximab in Relapsed/Refractory Diffuse Large B Cell Lymphoma
NCT00727584Radiation Therapy in Treating Patients With Metastatic Spinal Cord Compression
NCT01551459A Phase II Study of Sunitinib Versus Dacarbazine in the Treatment of Patients With Metastatic Uveal Melanoma
NCT03327662Utilising CTC Counts to Optimize Systemic Therapy of Metastatic Prostate Cancer
NCT03328247Achieving Self-directed Integrated Cancer Aftercare (ASICA) in Melanoma
NCT07172958Selective Antigen Specific T Cells and CAR T Cells in Subjects With Relapsed/Refractory Embryonal Tumors (SABRE)
NCT00004209Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer
NCT02960620Therasphere for Unresectable Primary or Secondary Liver Neoplasia
NCT00758173Study of Genes and the Environment in Patients With Prostate Cancer Residing in the East Anglia, Trent, or West Midlands Regions of the United Kingdom
NCT00450203Chemotherapy With or Without Bevacizumab or Lapatinib to Treat Operable Oesophagogastric Cancer
NCT03687645Hyperpolarised 13C-Pyruvate MRI Study
NCT066322365G-EMERALD: Amivantamab in Malignant Brain Tumours
NCT02124369Pancreatic Resectability in Cancers With Known Limited Extension (PRICKLE)
NCT05038657Atezolizumab Immunotherapy, in Immunotherapy Naive Patients With Urinary Tract Squamous Cell Carcinoma (UTSCC).
NCT01173900Delivery, Uptake and Acceptability of HPV Vaccination in Tanzanian Girls
NCT03705507International Trial of Selumetinib in Combination With Dexamethasone for the Treatment of Acute Lymphoblastic Leukaemia
NCT02874729Assay Development for Cancer Biomarkers
NCT00532194An RCT of Concurrent and Maintenance Cediranib in Women With Platinum-sensitive Relapsed Ovarian Cancer
NCT02688257Assessing Treatment Response in Breast Cancer With Functional Imaging
NCT06380816A Phase I/II Trial of UCB4594 in Participants With Advanced Cancer
NCT01566240Induction Chemotherapy Plus Chemoradiation as First Line Treatment for Locally Advanced Cervical Cancer
NCT00641095Phase III, Multicentre, Randomised Study of Fludarabine/Cyclophosphamide Combination With or Without Rituximab in Patients With Untreated Mantle Cell Lymphoma
NCT00562068Alemtuzumab and Combination Chemotherapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IV Peripheral T-Cell Lymphoma
NCT00967889Study of Tissue, Blood, and Urine Samples From Patients With Advanced Prostate Cancer
NCT07002320Investigating SX-682 in Combination With Apalutamide in Metastatic Castration-resistant Prostate Cancer
NCT02695966EVIS - Ex-vivo Assessment of T-lymphocyte Homing in Primary Pancreatic Cancer
NCT00907036Fludarabine Phosphate, Melphalan, and Alemtuzumab Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed Hodgkin Lymphoma
NCT00003969Geldanamycin Analogue in Treating Patients With Advanced Cancer
NCT03096093Investigation of a Therapeutic Vaccine (ACIT-1) in Cancer
NCT00532727Triple Negative Breast Cancer Trial
NCT06045910A Phase I/II Trial of ALETA-001 for the Treatment of Participants With B-cell Malignancies
NCT00814567Radiation Therapy in Women With Low Risk Early-Stage Breast Cancer Who Have Undergone Breast Conservation Surgery
NCT00963092Study of Blood and Tissue Samples From Patients With Stomach Cancer, Esophageal Cancer, or Gastroesophageal Junction Cancer
NCT04478929Early Detection of Barrett's Esophagus Through Deep Image Retrieval
NCT04842799Digital Delivery of Information About Genetic Testing for Breast Cancer
NCT00974792Combination Chemotherapy and Rituximab in Treating Patients With Diffuse Large B-Cell Non-Hodgkin Lymphoma
NCT02043899A Phase I/II Study of [124I]mIBG PET/CT in Neuroblastoma
NCT02761915A Phase I Trial of Anti-GD2 T-cells (1RG-CART)
NCT06086574Developing Circulating and Imaging Biomarkers Towards Personalised Radiotherapy in Lung Cancer
NCT01810757Study of Weekly Radiotherapy for Bladder Cancer
NCT02768337Cambridge Brain Mets Trial 1